Unbiased Phenotype-Based Screen Identifies Therapeutic Agents Selective for Metastatic Prostate Cancer.

Saved in:
Bibliographic Details
Title: Unbiased Phenotype-Based Screen Identifies Therapeutic Agents Selective for Metastatic Prostate Cancer.
Authors: Chung I; Vascular Biology Program, Boston Children's Hospital, Boston, MA, United States.; Department of Surgery, Harvard Medical School, Boston, MA, United States., Zhou K; Vascular Biology Program, Boston Children's Hospital, Boston, MA, United States.; Department of Surgery, Harvard Medical School, Boston, MA, United States., Barrows C; Vascular Biology Program, Boston Children's Hospital, Boston, MA, United States., Banyard J; Vascular Biology Program, Boston Children's Hospital, Boston, MA, United States.; Department of Surgery, Harvard Medical School, Boston, MA, United States., Wilson A; Vascular Biology Program, Boston Children's Hospital, Boston, MA, United States., Rummel N; Center for Veterinary Medicine, U.S. Food and Drug Administration, Washington, DC, United States., Mizokami A; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan., Basu S; Laboratory for Nanomedicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States., Sengupta P; Laboratory for Nanomedicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States., Shaikh B; Center for Veterinary Medicine, U.S. Food and Drug Administration, Washington, DC, United States., Sengupta S; Laboratory for Nanomedicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States., Bielenberg DR; Vascular Biology Program, Boston Children's Hospital, Boston, MA, United States.; Department of Surgery, Harvard Medical School, Boston, MA, United States., Zetter BR; Vascular Biology Program, Boston Children's Hospital, Boston, MA, United States.; Department of Surgery, Harvard Medical School, Boston, MA, United States.
Source: Frontiers in oncology [Front Oncol] 2021 Mar 02; Vol. 10, pp. 594141. Date of Electronic Publication: 2021 Mar 02 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2020.594141